Skip to main content
. 2024 Jan 5;19:11. doi: 10.1186/s13023-023-02996-9

Table 3.

Test–retest reliability (kappa coefficient) for main analysis

Item Overall GD1 GD2 GD3
n Estimate (95% CI) n Estimate (95% CI) n Estimate (95% CI) n Estimate (95% CI)
Part 1
P1-1 22 0.446 (−0.112, 1) 7 0.774 (0.774, 0.774) 9 −0.438 (−1, 1) 6 0.889 (0.714, 1)
P1-2 26 0.349 (−1, 1) 8 NA 10 −0.067 (−1, 1) 8 0.842 (0.842, 0.842)
P1-3 10 0.828 (0.828, 0.828) 4 NA 2 NA 4 0.750 (0.577, 0.923)
P1-4 27 0.468 (−0.158, 1) 8 NA 10 −0.067 (−1, 1) 9 0.787 (0.561, 1)
P1-5 25 0.556 (0.269, 0.844) 8 − 0.111 (−1, 1) 8 0.481 (−0.355, 1) 9 0.471 (−0.199, 1)
P1-6 28 0.612 (0.486, 0.738) 8 0.800 (0.800, 0.800) 11 0.193 (−0.775, 1) 9 0.769 (0.769, 0.769)
P1-7 24 0.286 (−1, 1) 8 0.778 (0.778, 0.778) 7 −0.235 (−1, 1) 9 0.542 (0.233, 0.852)
P1-8 26 0.438 (−0.788, 1) 8 0.373 (−1, 1) 9 0.091 (−0.847, 1) 9 0.890 (0.890, 0.890)
P1-9 23 0.390 (− 0.931, 1) 8 0.833 (0.833, 0.833) 7 0.222 (−1, 1) 8 0.517 (−0.179, 1)
P1-10 26 0.097 (−1, 1) 8 0.625 (0.625, 0.625) 10 −0.231 (−1, 1) 8 0.333 (−0.848, 1)
P1-11 28 0.487 (−1, 1) 8 0.867 (0.867, 0.867) 11 −0.039 (−1, 1) 9 0.679 (0.679, 0.679)
P1-12 24 0.538 (0.155, 0.922) 7 0.887 (0.705, 1) 8 0.132 (−1, 1) 9 0.518 (−0.365, 1)
P1-13 30 0.444 (−0.388, 1) 8 0.094 (−0.941, 1) 13 0.221 (−0.656, 1) 9 0.780 (0.780, 0.780)
P1-14 30 0.496 (−0.605, 1) 8 0.576 (−1, 1) 13 0.300 (−0.565, 1) 9 0.046 (−1, 1)
P1-15 30 0.608 (0.331, 0.884) 8 0.467 (−0.166, 1) 13 0.273 (−1, 1) 9 0.798 (0.798, 0.798)
Part 2
P2-1 29 0.971 (0.971, 0.971) 8 0.857 (0.857, 0.857) 12 0.175 (−1, 1) 9 0.976 (0.976, 0.976)
P2-2 29 0.562 (−1, 1) 7 0 (0, 0) 13 0.649 (0.649, 0.649) 9 0.434 (−1, 1)
P2-3 30 0.781 (0.781, 0.781) 8 0.364 (−0.215, 0.943) 13 0.787 (0.787, 0.787) 9 0.799 (0.799, 0.799)
P2-4 30 0.612 (0.612, 0.612) 8 0.298 (−0.500, 1) 13 0.363 (−0.397, 1) 9 0.917 (0.917, 0.917)
P2-5 30 0.746 (0.746, 0.746) 8 0.926 (0.926, 0.926) 13 0.483 (−1, 1) 9 0.900 (0.900, 0.900)
P2-6 30 0.630 (0.630, 0.630) 8 0.737 (0.737, 0.737) 13 0.458 (−0.287, 1) 9 0.739 (0.204, 1)
P2-7 30 0.658 (0.174, 1) 8 0.846 (0.846, 0.846) 13 0.703 (0.703, 0.703) 9 0.361 (−1, 1)
P2-8 30 0.582 (−0.003, 1) 8 0.793 (0.793, 0.793) 13 0.680 (0.172, 1) 9 0.247 (−1, 1)
P2-9 30 0.462 (−1, 1) 8 0.154 (−1, 1) 13 0.259 (−1, 1) 9 0.428 (−1, 1)
Part 3
P3-1 30 0.842 (0.842, 0.842) 8 0.769 (0.769, 0.769) 13 0.768 (0.768, 0.768) 9 0.967 (0.967, 0.967)
P3-2 30 0.683 (0.683, 0.683) 8 0.580 (−0.107, 1) 13 0.731 (0.731, 0.731) 9 0.749 (0.749, 0.749)
P3-3 30 0.868 (0.868, 0.868) 8 NA 13 0.786 (0.786, 0.786) 9 0.856 (0.856, 0.856)
P3-4 30 0.988 (0.988, 0.988) 8 0 (−1, 1) 13 0.988 (0.988, 0.988) 9 0.957 (0.957, 0.957)
P3-5 30 0.961 (0.961, 0.961) 8 0.760 (0.760, 0.760) 13 0.937 (0.937, 0.937) 9 0.942 (0.942, 0.942)
P3-6 29 0.855 (0.855, 0.855) 7 NA 13 0.869 (0.869, 0.869) 9 0.518 (−1, 1)
P3-7 30 0.803 (0.803, 0.803) 8 0.917 (0.917, 0.917) 13 0.692 (0.058, 1) 9 0.862 (0.862, 0.862)
P3-8 30 0.811 (0.811, 0.811) 8 0.609 (0.609, 0.609) 13 0.731 (0.731, 0.731) 9 0.947 (0.800, 1)
P3-9 30 0.266 (−1, 1) 8 0.191 (−0.206, 0.589) 13 0.248 (−0.665, 1) 9 0.286 (−0.0775, 1)
P3-10 30 0.659 (0.482, 0.835) 8 0.841 (0.600, 1) 13 0.511 (−0.486, 1) 9 0.654 (0.160, 1)
P3-11 30 0.536 (−1, 1) 8 0.167 (−1, 1) 13 0.277 (−1, 1) 9 0.930 (0.930, 0.930)
P3-12 29 0.608 (−0.024, 1) 8 0 (0, 0) 12 0.361 (−0.553, 1) 9 0.696 (0.048, 1)
P3-13 30 0.776 (0.776, 0.776) 8 0.632 (− 0.154, 1) 13 0.736 (0.359, 1) 9 0.860 (0.860, 0.860)
P3-14 30 0.782 (0.782, 0.782) 8 −0.070 (−1, 0.869) 13 0.759 (0.286, 1) 9 0.658 (0.658, 0.658)
P3-15 30 0.753 (0.753, 0.753) 8 −0.172 (−1, 1) 13 0.845 (0.845, 0.845) 9 0.657 (0.012, 1)
P3-16 27 0.514 (−0.255, 1) 6 0.848 (0.848, 0.848) 12 0.470 (−0.605, 1) 9 0.112 (−1, 1)

Kappa coefficients > 0.6 are in bold; coefficients < 0.2 are in italics. In general, a kappa coefficient < 0.2 indicates no agreement, 0.2–0.4 indicates minimal agreement, 0.4–0.6 indicates weak agreement, 0.6–0.8 indicates moderate agreement, 0.8–0.9 indicates strong agreement, and > 0.9 indicates almost perfect agreement [29]

CI: confidence interval; GD1/2/3: type 1/2/3 Gaucher disease; NA: not applicable; P: Part